Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of APGE will rise by +0.42% over the next 2 Weeks and hit $135.64 by Wednesday, September 16, 2026. In that time frame, APGE's share price is expected to range between $131.11 and $140.68.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 16, 2026 | 131.34 | 135.54 | 140.05 |
| Sep 15, 2026 | 131.88 | 135.50 | 139.39 |
| Sep 14, 2026 | 132.46 | 135.48 | 138.79 |
| Sep 11, 2026 | 132.93 | 135.40 | 138.05 |
| Sep 10, 2026 | 133.39 | 135.35 | 137.44 |
| Sep 9, 2026 | 133.83 | 135.33 | 136.82 |
| Sep 8, 2026 | 134.23 | 135.28 | 136.33 |
| Sep 7, 2026 | 134.62 | 135.27 | 135.92 |
| Sep 4, 2026 | 134.86 | 135.19 | 135.52 |
| Sep 3, 2026 | 135.03 | 135.14 | 135.25 |
APGE shares remained flat 0 in Friday, September 4, 2026's trading session, starting and closing at a previous close of $135.07 to move at $135.07. The stock demonstrated notable intraday movement (see APGE's key stats for a full breakdown), fluctuating between $135.07 and $135.07, a 0 trading range. While recent weeks have seen some volatility, APGE has managed to secure a +0.24% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 4.95M shares changing hands, 3.87M more than the previous session. This amounted to $668.19M in total market activity.
Will APGE Continue Its Upward Trend?
According to analyst ratings and projections for APGE, Apogee Therapeutics, Inc. shares are anticipated to increase by +3.56%, potentially reaching $140.05 per share by September 16, 2026. Short-term technical indicators currently suggest a neutral sentiment for APGE. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 20 positive trading days within the past 30 sessions. Based on the APGE stock forecast, now is a good time to buy APGE stock because its current trading price is -0.35% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on APGE covering social and institutional perspectives.
APGE Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into APGE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 76.37% to 80.23%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 68.71%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 64.23%, points to growing bullish momentum over the long term. Insights into APGE's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Apogee Therapeutics Short-Term Forecasts
APGE Forecast For Next 5 Days
Our algorithm anticipates Apogee Therapeutics (APGE) stock could hit $133.78 by Sep 17, 2026. This represents a -0.96% rise from today's price, following a +5.65% change over the past five days.
APGE Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Apogee Therapeutics, Inc. (APGE) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $135.54, which would mean a +0.35% increase from the current price of $135.07. Projections for this period range from a high of $148.82 to a low of $119.74.
APGE Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Apogee Therapeutics's price over the next three months point to a drop. APGE stock is expected to peak at $106.22 on Nov 23, 2026 after potentially dipping to $80.41 on Oct 12, 2026. On average, APGE is likely to trade around $92.27 in the coming 90 days.
Apogee Therapeutics Stock Forecast 2025
Based on our predictive models, Apogee Therapeutics (APGE) is expected to trade between $80.41 and $106.98 throughout 2026. This would result in an average price of $93.18, potentially offering investors a -31.01% return from current levels.
Apogee Therapeutics, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Apogee Therapeutics, Inc. (APGE) is positioned to show a strong performance in September 2026. The price is predicted to move between $82.72 and $99.13, settling at an average of $90.77. This could translate to a -32.80% loss.
October 2026
Based on current market signals, Apogee Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $80.41 to $99.18, with a likely average price of $89.74. Investors could expect a potential return of -33.56%.
November 2026
Our predictive algorithms indicate Apogee Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $83.36–$106.22, with an average target of $94.81. This represents a cautious outlook and a possible loss of -29.81%.
December 2026
Analyzing established trends, Apogee Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $85.92 and $106.98, averaging around $96.54. This suggests a -28.53% loss from current levels.
January 2027
Market indicators suggest Apogee Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $91.91 to $113.26, with a midpoint forecast of $102.34. The stock might deliver a -24.23% loss.
February 2027
Forecasting for February 2027, models estimate that Apogee Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $91.88 and $109.38, averaging $100.56. This signals a cautious trajectory with potential returns around -25.55%.
March 2027
According to our latest forecast models, Apogee Therapeutics, Inc. (APGE) is positioned to show a strong performance in March 2027. The price is predicted to move between $90.71 and $109.79, settling at an average of $99.74. This could translate to a -26.16% loss.
April 2027
Based on current market signals, Apogee Therapeutics, Inc. is projected to trend april 2027. We forecast a trading range from $93.97 to $116.33, with a likely average price of $104.42. Investors could expect a potential return of -22.69%.
May 2027
Our predictive algorithms indicate Apogee Therapeutics, Inc. stock may see a shift in May 2027. The expected range spans $96.87–$116.60, with an average target of $106.39. This represents a cautious outlook and a possible loss of -21.23%.
June 2027
Analyzing established trends, Apogee Therapeutics, Inc. looks set to move in June 2027. Projections place the stock between $102.12 and $123.24, averaging around $111.96. This suggests a -17.11% loss from current levels.
July 2027
Market indicators suggest Apogee Therapeutics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $101.81 to $118.97, with a midpoint forecast of $110.07. The stock might deliver a -18.51% loss.
August 2027
Forecasting for August 2027, models estimate that Apogee Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $101.27 and $120.34, averaging $109.75. This signals a cautious trajectory with potential returns around -18.75%.
September 2027
According to our latest forecast models, Apogee Therapeutics, Inc. (APGE) is positioned to show a strong performance in September 2027. The price is predicted to move between $105.81 and $121.15, settling at an average of $112.70. This could translate to a -16.56% loss.
APGE's history of dividends and stock splits also plays a role in long-term investor confidence.